Agena Bioscience and nRichDX said Friday that they have entered a commercial partnership to co-promote their products to researchers developing liquid biopsy applications on Agena's MassArray platform.

Naveris said Wednesday that Mayo Clinic began a Phase II trial of its circulating tumor DNA blood test, NavDx, to guide treatment for patients with HPV-driven head and neck cancer.

Agilent Technologies Inc. announced a strategic partnership with PathAI, a leading provider of AI-powered research tools and services for pathology, to deliver biopharmaceutical organizations a solution that combines Agilent’s assay development expertise and PathAI’s algorithm development capabilities.

Avalon GloboCare and Qi Diagnostics on Tuesday announced their intention to co-develop a breathalyzer device for screening and the early detection of lung cancer.

Foundation Medicine said Tuesday that it has expanded an ongoing collaboration with Bristol Myers Squibb to include companion diagnostic development for the pharma firm's investigational tyrosine kinase inhibitor repotrectinib.

Ultima Genomics and Genome Insight said on Monday that they are collaborating to develop affordable whole-genome sequencing testing for cancer patients.

On April 7, 2023, the "Molecular Diagnostics Joint Laboratory" jointly built by the Key Laboratory of Medical Molecular Virology of Fudan University, Ministry of Education/Health and Health Commission/ Academy of Medical Sciences and Liferiver Bio-Tech.

Sysmex Europe and Cerca Biotech said Monday that they have inked a deal for Sysmex to distribute Cerca's molecular breast cancer assay in 13 European markets.

On March 29, 2023, Hybribio and MGI Tech signed an agreement to reach strategic cooperation in the direction of high-throughput sequencing platform to expand international market.

​​Magtivio, a magnetic bead manufacturer from The Netherlands announces a distribution agreement with Premedical Lab from Beijing, China, a professional laboratory products distribution company in the life sciences arena.